During the past decade, Cancer Treatment Centers of America conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cancer Treatment Centers of America" #1 sponsor was "National Cancer Institute (NCI)" with 10 trials, followed by "SWOG Cancer Research Network" with 3 trials sponsored, "Galena Biopharma, Inc." with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Auris Health, Inc." with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Treatment Centers of America" #1 collaborator was "NRG Oncology" with 6 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Cancer Treatment Centers of America" are "Recurrent Ovarian Carcinoma" (3 trials), "Breast Cancer" (2 trials), "Cholangiocarcinoma" (2 trials), "Fallopian Tube Transitional Cell Carcinoma" (2 trials) and "Melanoma" (2 trials). Many other conditions were trialed in "Cancer Treatment Centers of America" in a lesser frequency.

Most popular intervention types in "Cancer Treatment Centers of America" are "Drug" (17 trials), "Other" (9 trials), "Procedure" (9 trials), "Biological" (8 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (5 trials), "Computed Tomography" (5 trials), "Quality-of-Life Assessment" (5 trials), "Biospecimen Collection" (4 trials) and "Magnetic Resonance Imaging" (4 trials). Other intervention names were less common.

The vast majority of trials in "Cancer Treatment Centers of America" are 16 trials for "All" genders, 3 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Cancer Treatment Centers of America". undefined are not yet recruiting, 4 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cancer Treatment Centers of America, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cancer Treatment Centers of America, 0 "Phase 1" clinical trials were conducted, 12 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Cancer Treatment Centers of America has several departments that took part in Clinical trials: "Cancer Treatment Centers of America" - 22 trials